Bank of New York Mellon Corp Sells 56,873 Shares of Docusign Inc. $DOCU

Bank of New York Mellon Corp trimmed its stake in Docusign Inc. (NASDAQ:DOCU) by 3.6% in the fourth quarter, HoldingsChannel.com reports. The firm owned 1,538,011 shares of the company’s stock after selling 56,873 shares during the period. Bank of New York Mellon Corp’s holdings in Docusign were worth $105,200,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Natixis Advisors LLC lifted its holdings in Docusign by 24.6% during the 4th quarter. Natixis Advisors LLC now owns 15,649 shares of the company’s stock worth $1,070,000 after buying an additional 3,093 shares during the period. AXQ Capital LP bought a new position in Docusign during the 4th quarter worth approximately $286,000. Essex Financial Services Inc. increased its position in shares of Docusign by 7.2% during the fourth quarter. Essex Financial Services Inc. now owns 6,334 shares of the company’s stock worth $433,000 after buying an additional 424 shares during the period. BNP Paribas Financial Markets raised its stake in Docusign by 89.9% during the fourth quarter. BNP Paribas Financial Markets now owns 299,312 shares of the company’s stock worth $20,473,000 after buying an additional 141,724 shares during the last quarter. Finally, Forsta AP Fonden raised its stake in Docusign by 0.7% during the fourth quarter. Forsta AP Fonden now owns 134,900 shares of the company’s stock worth $9,227,000 after buying an additional 1,000 shares during the last quarter. 77.64% of the stock is owned by institutional investors.

Insider Activity at Docusign

In related news, CEO Allan C. Thygesen sold 26,250 shares of the business’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $47.78, for a total value of $1,254,225.00. Following the transaction, the chief executive officer directly owned 152,237 shares of the company’s stock, valued at approximately $7,273,883.86. The trade was a 14.71% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CRO Paula Hansen sold 6,000 shares of the stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $46.84, for a total transaction of $281,040.00. Following the transaction, the executive owned 79,233 shares of the company’s stock, valued at approximately $3,711,273.72. The trade was a 7.04% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 65,489 shares of company stock valued at $3,125,814 in the last ninety days. Insiders own 0.59% of the company’s stock.

Docusign Stock Performance

Shares of NASDAQ:DOCU opened at $47.26 on Monday. The stock has a market cap of $9.18 billion, a PE ratio of 30.69, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. Docusign Inc. has a 1-year low of $40.16 and a 1-year high of $86.65. The stock’s fifty day simple moving average is $47.76 and its two-hundred day simple moving average is $54.09.

Docusign (NASDAQ:DOCU) last posted its earnings results on Thursday, June 4th. The company reported $1.09 EPS for the quarter, topping the consensus estimate of $0.99 by $0.10. Docusign had a net margin of 9.59% and a return on equity of 17.48%. The firm had revenue of $830.24 million for the quarter, compared to analysts’ expectations of $824.71 million. During the same quarter last year, the firm earned $0.90 EPS. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. On average, sell-side analysts forecast that Docusign Inc. will post 1.76 earnings per share for the current fiscal year.

Docusign declared that its Board of Directors has approved a share repurchase plan on Tuesday, March 17th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 21% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s board of directors believes its shares are undervalued.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: DocuSign beat first-quarter expectations, posting adjusted EPS of $1.09 versus $1.00 expected and revenue of $830.2 million versus $823.2 million estimated, with sales up 8.7% year over year. DocuSign Beats Fiscal Q1 Estimates, but IAM Traction Remains in Focus, RBC Says
• Positive Sentiment: The company said adoption of its AI-powered Intelligent Agreement Management platform is improving, and it raised full-year revenue guidance slightly, indicating demand remains healthy. DocuSign Nudges Revenue Outlook Higher After First-Quarter Profit Rises
• Neutral Sentiment: Analyst commentary remains mixed, with Wedbush lowering its price target to $58 from $60 while keeping a neutral rating, and BTIG cutting its target to $60 from $70 but maintaining a buy rating.
• Neutral Sentiment: DocuSign also highlighted AI integrations, including ChatGPT and Codex, and continued share repurchases, which support the long-term story but were not enough to offset near-term guidance concerns. Docusign Inc (DOCU) Q1 2027 Earnings Call Highlights
• Negative Sentiment: Shares moved lower because the full-year outlook did not meaningfully exceed Wall Street expectations, dampening enthusiasm despite the earnings beat and prompting a “sell-the-news” reaction. DocuSign shares fall despite Q1 beat as guidance disappoints investors
• Negative Sentiment: Investors also appear to be focusing on whether DocuSign can accelerate growth beyond the low-double-digit range, as recent reports say the outlook “left investors looking for stronger signs of accelerating growth.” DocuSign stock falls as cautious outlook overshadows earnings beat

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on DOCU shares. UBS Group set a $60.00 target price on Docusign in a research report on Friday. Citizens Jmp cut their price target on Docusign from $124.00 to $86.00 and set a “market outperform” rating on the stock in a report on Wednesday, March 18th. Wells Fargo & Company reduced their price objective on shares of Docusign from $60.00 to $55.00 and set an “equal weight” rating for the company in a research report on Friday. Bank of America began coverage on shares of Docusign in a research note on Tuesday, March 31st. They issued an “underperform” rating and a $52.00 price objective for the company. Finally, JPMorgan Chase & Co. decreased their target price on Docusign from $78.00 to $65.00 and set a “neutral” rating for the company in a research report on Wednesday, March 18th. Three research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $60.27.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.